Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4136

1.

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M.

Hepat Med. 2015 Apr 13;7:1-10. doi: 10.2147/HMER.S50161. eCollection 2015. Review.

2.

Serum and Urine Biomarkers for Human Renal Cell Carcinoma.

Pastore AL, Palleschi G, Silvestri L, Moschese D, Ricci S, Petrozza V, Carbone A, Di Carlo A.

Dis Markers. 2015;2015:251403. Epub 2015 Apr 2. Review.

3.

Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs.

Locarnini S, Hatzakis A, Chen DS, Lok A.

J Hepatol. 2015 Apr;62(1S):S76-S86. doi: 10.1016/j.jhep.2015.01.018. Review.

4.

NAFLD: A multisystem disease.

Byrne CD, Targher G.

J Hepatol. 2015 Apr;62(1S):S47-S64. doi: 10.1016/j.jhep.2014.12.012. Review.

5.

Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.

Lu J, Gu J.

Molecules. 2015 Apr 24;20(5):7509-7527. Review.

6.

Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges.

Deng GL, Zeng S, Shen H.

World J Hepatol. 2015 Apr 18;7(5):787-98. doi: 10.4254/wjh.v7.i5.787. Review.

7.

Hepatitis D and hepatocellular carcinoma.

Abbas Z, Abbas M, Abbas S, Shazi L.

World J Hepatol. 2015 Apr 18;7(5):777-86. doi: 10.4254/wjh.v7.i5.777. Review.

8.

Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives.

Mosconi C, Cappelli A, Pettinato C, Golfieri R.

World J Hepatol. 2015 Apr 18;7(5):738-52. doi: 10.4254/wjh.v7.i5.738. Review.

9.

Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Barth H.

World J Hepatol. 2015 Apr 18;7(5):725-37. doi: 10.4254/wjh.v7.i5.725. Review.

10.

Oral submucous fibrosis: an update.

Wollina U, Verma SB, Ali FM, Patil K.

Clin Cosmet Investig Dermatol. 2015 Apr 13;8:193-204. doi: 10.2147/CCID.S80576. eCollection 2015. Review.

11.

Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.

Sankin A, Hakimi AA, Hsieh JJ, Molina AM.

Front Oncol. 2015 Apr 8;5:67. doi: 10.3389/fonc.2015.00067. eCollection 2015. Review.

12.

Optimal management of biopsy-proven low-grade gastric dysplasia.

Kim JW, Jang JY.

World J Gastrointest Endosc. 2015 Apr 16;7(4):396-402. doi: 10.4253/wjge.v7.i4.396. Review.

13.

Future directions of duodenal endoscopic submucosal dissection.

Matsumoto S, Miyatani H, Yoshida Y.

World J Gastrointest Endosc. 2015 Apr 16;7(4):389-95. doi: 10.4253/wjge.v7.i4.389. Review.

14.

HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer.

Indira Chandran V, Eppenberger-Castori S, Venkatesh T, Vine KL, Ranson M.

Oncoscience. 2015 Mar 23;2(3):207-24. eCollection 2015. Review.

15.

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies.

Bertino G, Demma S, Ardiri A, Proiti M, Mangia A, Gruttadauria S, Toro A, Di Carlo I, Malaguarnera G, Bertino N, Malaguarnera M, Malaguarnera M.

Biomed Res Int. 2015;2015:731469. Epub 2015 Mar 29. Review.

16.

Afamin - A pleiotropic glycoprotein involved in various disease states.

Dieplinger H, Dieplinger B.

Clin Chim Acta. 2015 Apr 16;446:105-110. doi: 10.1016/j.cca.2015.04.010. [Epub ahead of print] Review.

17.

Adrenal tumors with unexpected outcome: a review of the literature.

Kerkhofs TM, Roumen RM, Demeyere TB, van der Linden AN, Haak HR.

Int J Endocrinol. 2015;2015:710514. doi: 10.1155/2015/710514. Epub 2015 Mar 25. Review.

18.

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?

Shahait M, Mukherji D, El-Hout Y.

Indian J Urol. 2015 Apr-Jun;31(2):102-5. doi: 10.4103/0970-1591.154300. Review.

19.

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease.

Paschetta E, Belci P, Alisi A, Liccardo D, Cutrera R, Musso G, Nobili V.

Mediators Inflamm. 2015;2015:815721. Epub 2015 Mar 19. Review.

20.

The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Domagala-Kulawik J.

Transl Lung Cancer Res. 2015 Apr;4(2):177-90. doi: 10.3978/j.issn.2218-6751.2015.01.11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk